Pharmacology and Toxicology Department Highlights: February 2020

(February 1, 2020) 

Publications 

Non-enzymatic Lysine Lactoylation of Glycolytic Enzymes. Cell Chemical Biology. 2019.11.005.

Interaction of Oatp1b2 expression and nonalcoholic steatohepatitis on pravastatin plasma clearance. Biochem Pharmacol. 2019 Dec 24:113780.

Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model. Acta Pharmaceutica Sinica B. 10: 123-135, 2020.

 


Presentations

Georg Wondrak, PhD

  • "Investigating the Molecular Potentiation of Cutaneous and Systemic Damage Inflicted by Co-Exposure to Solar UV Radiation and Chlorination Stress Originating from Swimming Pool Disinfectants." presented at American College of Toxicology Annual Meeting during 'Hot Topics’ session, Phoenix, AZ, November, 2019. 

"In Vitro Aerosol Deposition Performance of Dry Powder Inhaler Particles of Metformin Using Different FDA Approved Human Dry Powder Inhaler Devices." National Presentation at ASHP Midyear, Las Vegas, NV, December 2019.

 


Kudos

SAMUEL YALKOWSKY, PHD awarded AAPS Distinguished Pharmaceutical Scientists Awards.

Georg Wondrak, PhD, Associate Professor, Pharmacology and Toxicology, serves as a Guest editor for a Special Issue entitled: ‘Redox Dysregulation and Oxidative Stress in Cancer: Therapeutic Targets and Opportunities’ published in the journal ‘Cancers’ [IF: 6.2].  Submissions deadline: 1 June 2020. Website: https://www.mdpi.com/journal/cancers/special_issues/redox